Preoperative Fibrinogen-Albumin Ratio, Potential Prognostic Factors for Bladder Cancer Patients Undergoing Radical Cystectomy: A Two-Center Study

被引:11
作者
Chen, Jiangang [1 ,2 ]
Hao, Lin [1 ,3 ]
Zhang, Shaoqi [1 ]
Zhang, Yong [2 ]
Dong, Bingzheng [1 ,3 ]
Zhang, Qianjin [1 ]
Han, Conghui [1 ,3 ]
机构
[1] Soochow Univ, Med Coll, Suzhou 215123, Jiangsu, Peoples R China
[2] Nantong Univ, Affiliated Hosp 2, Dept Urol, Nantong 226001, Jiangsu, Peoples R China
[3] Xuzhou Med Univ, Dept Urol, Xuzhou Cent Hosp, Xuzhou Clin Coll, 199 Jiefang South Rd, Xuzhou 221009, Jiangsu, Peoples R China
关键词
fibrinogen-albumin ratio; bladder cancer; radical cystectomy; overall survival; progression-free survival; CARCINOMA;
D O I
10.2147/CMAR.S300574
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We conducted a two-center study to investigate the prognostic value of preoperative fibrinogen-albumin ratio (FAR) in patients undergoing radical cystectomy (RC). Methods: The clinical and survival data of 267 patients with bladder cancer (BCa) treated with RC were collected, of which 140 patients from Xuzhou Central Hospital were divided into training set and 127 patients from The Second Affiliated Hospital of Nantong University were divided into validation set. X-tile software was used to obtain the optimal cut-off values for preoperative platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and FAR. Receiver operating characteristic (ROC) curves were used to compare the predictive ability of PLR, NLR, FAR and modified Glasgow prognostic score (mGPS). Kaplan-Meier curves were used to assess overall survival (OS) and progression-free survival (PFS) of patients in different FAR groups. Univariate and multivariate Cox regression were used to assess patients' independent risk factors, and R software was used to construct prognostic nomograms. Results: In the training set, the optimal cut-off values for PLR, NLR and FAR were 76.76, 3.97 and 0.08, respectively. Both in the training and validation sets, FAR had better ability to predict OS and PFS than PLR and NLR, and patients in the higher FAR group had worse OS and PFS. In the multivariate Cox regression analysis, FAR was an independent risk factor for OS [hazard ratio (HR) 3.569, 95% confidence interval (CI): 1.015-12.546, P=0.047] and PFS [HR 5.071, 95% CI: 1.394-18.451, P=0.014]. In addition, FAR-based prognostic nomograms had high predictive ability than TNM staging. Conclusion: Preoperative FAR is an independent prognostic factor for OS and PFS in BCa patients treated with RC, and a high FAR predicted a poor prognosis. In addition, a prognostic nomogram based on FAR can better predict individual survival.
引用
收藏
页码:3181 / 3192
页数:12
相关论文
共 28 条
[1]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 [J].
Babjuk, Marko ;
Boehle, Andreas ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Hernandez, Virginia ;
Kaasinen, Eero ;
Palou, Joan ;
Roupret, Morgan ;
van Rhijn, Bas W. G. ;
Shariat, Shahrokh F. ;
Soukup, Viktor ;
Sylvester, Richard J. ;
Zigeuner, Richard .
EUROPEAN UROLOGY, 2017, 71 (03) :447-461
[2]   Fibrinogen: a journey into biotechnology [J].
Bratek-Skicki, Anna ;
Zeliszewska, Paulina ;
Ruso, Juan M. .
SOFT MATTER, 2016, 12 (42) :8639-8653
[3]   Origins of Bladder Cancer [J].
Czerniak, Bogdan ;
Dinney, Colin ;
McConkey, David .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11, 2016, 11 :149-174
[4]  
Enquselassie F., 2014, ETHIOP MED J, V52
[5]   Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor [J].
Ferro, M. ;
Di Lorenzo, G. ;
Vartolomei, M. D. ;
Bruzzese, D. ;
Cantiello, F. ;
Lucarelli, G. ;
Musi, G. ;
Di Stasi, S. ;
Hurle, R. ;
Guazzoni, G. ;
Busetto, G. M. ;
Gabriele, A. ;
Del Giudice, F. ;
Damiano, R. ;
Perri, F. ;
Perdona, S. ;
Verze, P. ;
Borghesi, M. ;
Schiavina, R. ;
Almeida, G. L. ;
Bove, P. ;
Lima, E. ;
Autorino, R. ;
Crisan, N. ;
Abu Farhan, A. R. ;
Battaglia, M. ;
Russo, G. I. ;
Ieluzzi, Vincenzo ;
Morgia, G. ;
De Placido, P. ;
Terracciano, D. ;
Cimmino, A. ;
Scafuri, L. ;
Mirone, V. ;
De Cobelli, O. ;
Shariat, S. ;
Sonpavde, Guru ;
Buonerba, C. .
WORLD JOURNAL OF UROLOGY, 2020, 38 (01) :143-150
[6]   Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor [J].
Ferro, Matteo ;
Katalin, Martha Orsolya ;
Buonerba, Carlo ;
Marian, Raluca ;
Cantiello, Francesco ;
Musi, Gennaro ;
Di Stasi, Savino ;
Hurle, Rodolfo ;
Guazzoni, Giorgio ;
Busetto, Gian Maria ;
Del Giudice, Francesco ;
Perdona, Sisto ;
Del Prete, Paola ;
Mirone, Vincenzo ;
Borghesi, Marco ;
Porreca, Angelo ;
Artibani, Walter ;
Bove, Pierluigi ;
Lima, Estevao ;
Autorino, Riccardo ;
Crisan, Nicolae ;
Abu Farhan, Abdal Rahman ;
Battaglia, Michele ;
Ditonno, Pasquale ;
Serretta, Vincenzo ;
Russo, Giorgio Ivan ;
Terracciano, Daniela ;
di Lorenzo, Giuseppe ;
Damiano, Rocco ;
Sonpavde, Guru ;
Vartolomei, Mihai Dorin ;
de Cobelli, Ottavio ;
Lucarelli, Giuseppe .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (05) :459-464
[7]   Awakening immunity against cancer: a 2017 primer for clinicians [J].
Jain, Amit ;
Zhang, Qing ;
Toh, Han-Chong .
CHINESE JOURNAL OF CANCER, 2017, 36
[8]   The relationship between serum albumin and hydration status in hemodialysis patients [J].
Jones, CH ;
Akbani, H ;
Croft, DC ;
Worth, DP .
JOURNAL OF RENAL NUTRITION, 2002, 12 (04) :209-212
[9]   Fibrin and Fibrinolysis in Cancer [J].
Kwaan, Hau C. ;
Lindholm, Paul F. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (04) :413-422
[10]   CHANGE IN FIBRINOGEN TURNOVER IN TUMORS BY HYPERTHERMIA [J].
LEE, SY ;
SONG, CW ;
LEVITT, SH .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (12) :1507-&